Yesterday's court decision denying a right for terminal patients to access unapproved medications was a setback to patient advocacy groups seeking untested drugs that might save their lives. The 8-2 decision by the full Court of Appeals for the District of Columbia Circuit overturned a previous ruling by its panel supporting the Abigail Alliance for Better Access to Developmental Drugs, a group inspired by the death of 21-year-old Abigail from cancer as she fought for experimental...